- Eli Lilly Shares Slide as Weight-Loss Pill Results Dent Enthusiasm The Wall Street Journal
- Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop CNBC
- Eli Lilly’s key obesity pill falls short of rivals, but the company still beat on earnings statnews.com
- Experimental GLP-1 pill helped people with obesity lose weight, Eli Lilly says CNN
- Daily oral GLP-1 pill could be just as effective as weekly shots: Drugmaker ABC News
Source link
